MKI67 and glioblastoma: Our data here suggest that this also happens in GBM, showing low ratios in more proliferative tumors (calculation of GFAP/MHCII measured volume ratios shows: TSR for Ki67 30%, 3; Ki67 20%, 8; Ki67 10%, 33).